Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 92

NCT04599478

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Behavioral Weight Loss (BWL) + Naltrexone and Bupropion (NB) medication7 participants2 participants3 participantsn/r0
BWL + Placebo0 participants0 participants3 participantsn/r0
NB medicationn/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.